Scholars Central

Conference abstractPublished 3 Oct 2016

Remodeling of Tannic Acid Crosslinked Collagen Type I Induces Apoptosis in ER+ and HER2+ Breast Cancer Cells

Authors: Brian W. Booth

Clemson University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Breast cancer accounts for almost 30$ of new cancer diagnoses and is one of the leading causes of cancer deaths in developed countries. Lumpectomy is a common procedure to remove breast tumors resulting in a tissue void. There are currently no highly regarded surgical techniques to repair these voids. The objective of this project is to develop an injectable tissue regeneration matrix with anti-cancer properties. Collagen type I is a common tissue-engineering scaffold due to its intrinsically bioactive and biodegradable qualities. Collagen is a naturally derived material and, when not crosslinked, is enzymatically degraded. Research efforts targeting the potential of natural compounds in the fight against cancer are growing. Tannic acid (TA) belongs to the class of hydrolysable tannins and is found in numerous plants and foods. TA functions as a collagen crosslinking agent through both hydrogen bonding and hydrophobic effects; thus, as crosslinked collagen is remodeled TA is released. If used as a biomaterial for tissue-engineering purposes, TA-crosslinked collaged type I would not only serve as an attachment scaffold for cells but also function as an extended release anti-cancer treatment. When normal adipocytes attach and grow on TA-crosslinked collagen type I beads the released TA induces apoptosis in ER+ and HER2+ breast cancer cells with minimal impact on normal breast epithelial cells and adipocytes. The TA-induced apoptosis is mediated by caspases 3, 7 and 9. In conclusion, TA-crosslinked collagen beads show promise as a potential tissue regeneration matrix while providing an anti-cancer effect.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Brian W. Booth”